Xcout IntelSign inSubscribe

BECTON, DICKINSON

1BDXMedical DevicesUnited States

Becton, Dickinson and Company (BD) is a global medical technology company that manufactures and provides medical devices, instrument systems, and reagents. It serves healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry with solutions for medication management, diagnostics, infection prevention, and surgery.

Subscribe to see BECTON, DICKINSON’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Industry
Medical Devices
Headquarters
United States
Ticker
1BDX

BECTON, DICKINSON competitors

A few of BECTON, DICKINSON's closest competitors — see the full list of competitors and alternatives →

Bio-Rad LaboratoriesBIO · Medical DevicesHercules, United States
69% matchPublic

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Market cap$9.9B
Employees7,450
Bio-Rad Laboratories competitors & alternatives →

Get BECTON, DICKINSON's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

BECTON, DICKINSON — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on BECTON, DICKINSON in Xcout Intel

  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →